Press Releases

Roquette’s 2025 results show the resilience of its expanded portfolio in a very difficult market environment.

Uniting Expertise for Sustainable Beauty. Roquette announces a new chapter for its cosmetics activity, known as Roquette Beauté, with the introduction of an enriched portfolio.

Roquette has been awarded the EcoVadis Gold Medal and has participated in the CDP’s annual assessment to evaluate its environmental management practices, earning a B score for both Climate and Water.

NUTRALYS® Pea 850F is Roquette’s latest pea protein isolate, representing a breakthrough in delivering a clean, neutral taste for plant-based product formulations.

Roquette announces that its NUTRIOSE^® soluble fibers that hold clinical evidence of health benefits have now also gained NutraStrong™ Prebiotic Verified product certification from SGS Nutrasource.

Roquette marks a step forward in its commitment to sustainable farming practices by expanding and renaming its plant care activity, now known as Agriscience.

Roquette Launches HORIZONS, a new platform created to help food and nutrition businesses anticipate change, explore possible futures, and transform uncertainty into actionable strategies.

Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC) has been awarded first place in the Excipients/Non-Actives category at the 2025 NIE New Ingredient Awards,

Roquette showcases technical expertise with 14 poster presentations and four speaker sessions to meet the evolving needs of pharmaceutical developers.

Roquette has introduced AMYSTA™ L 123 thermally soluble pea starch, the first innovation in its new AMYSTA™ label-friendly starch range.

The Health & Pharma Solutions facility offers state-of-the-art laboratory and training rooms for customers, as part of Roquette’s new Pharmaceutical Innovation Center in São Paulo, to strengthen Latin America as a collaborative hub for health and pharma solutions.

Showcasing the combined strength of Roquette’s Health & Pharma Solutions’ capabilities in excipients, capsules, APIs, and drug delivery technologies at CPhI 2025.

Roquette Boosts Extensive Cyclodextrins Portfolio with Launch of KLEPTOSE® Crysmeb Methyl-Beta-Cyclodextrin for Oral and Parenteral Formulations.

Announcement of Roquette 2025 H1 results, following the approval of its financial statements by the Board of Directors.

The new ingredients are designed to help food manufacturers meet growing demand for nutritious, affordable, and sustainable proteins.